Viewing nowLosartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
White Life Science Co., Ltd.

MFDS item code 201309287 · Approved 2013.09.11 · Insurance code 625200120
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension. It helps to slow the progression of kidney disease, particularly in patients with type 2 diabetes and hypertension. Thus, it is used as an effective treatment for both hypertension management and kidney function protection.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular blood volume For patients who may have decreased effective intravascular blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Pediatric patients and adolescents aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) This medicine is not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Do not use this medication in individuals with hypersensitivity to it, pregnant women or women of childbearing potential, patients with severe liver impairment, certain hereditary angioedema patients, or those with primary hyperaldosteronism. Additionally, patients with genetic conditions such as lactose intolerance should not take this medication. Elderly patients, those with hyperkalemia, liver impairment, valvular heart disease, obstructive cardiomyopathy, or patients at risk of rapid blood pressure drops should use this medication cautiously. This medication is used relatively safely in hypertensive patients, but various side effects such as dizziness, muscle cramps, back pain, and respiratory infections may occur, so any abnormal symptoms should be discussed with a doctor. Serious side effects such as angioedema, liver function abnormalities, myalgia, hyperkalemia, hypotension, and renal failure have been rarely reported and require caution. Patients with impaired liver function may have elevated blood levels of this medication, so dosage adjustments are necessary; similarly, patients with poor kidney function should use it cautiously. This medication can increase potassium levels, so it is advisable not to take it with potassium supplements or potassium-sparing diuretics. Also, be cautious that when used in conjunction with non-steroidal anti-inflammatory drugs (NSAIDs), the blood pressure-lowering effect may decrease, and renal function may worsen. Patients taking this medication should have their blood pressure, kidney function, and electrolyte levels checked regularly, and if symptoms worsen, they should consult a doctor immediately. Women who are pregnant or breastfeeding should avoid taking this medication and should decide in consultation with a specialist if necessary. Children, especially those under 6 years of age or with severely impaired kidney function, should not use this medication. In case of overdose, hypotension and bradycardia may occur, so appropriate treatment should be sought immediately at a medical facility. Store this medication in a safe place out of the reach of children and avoid transferring it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture. Additionally, it is recommended to store the medication at room temperature between 1 and 30 degrees Celsius, avoiding extremes of heat or cold.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
White Life Science Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.